• Return to Headlines

Enzo Biochem, Inc. has the Lowest Debt-to-Capital Ratio in the Life Sciences Tools & Services Industry (ENZ, CBM, BIO, PACB, TECH)

By Shiri Gupta

Below are the three companies in the Life Sciences Tools & Services industry with the lowest Debt-to-Capital ratios. The debt-to-capital ratio is an important measure of how a company is financing its operations along with some insight into its financial strength, relative to other companies in its industry.

Enzo Biochem, Inc. ranks lowest with a a Debt-to-Capital ratio of 84.8%. Cambrex Corp is next with a a Debt-to-Capital ratio of 668.0%. Bio-Rad Labs-A ranks third lowest with a a Debt-to-Capital ratio of 1,292.6%.

Pacific Bioscien follows with a a Debt-to-Capital ratio of 1,367.1%, and Bio-Techne Corp rounds out the bottom five with a a Debt-to-Capital ratio of 2,657.9%.

SmarTrend is monitoring the recent change of momentum in Bio-Techne Corp. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Bio-Techne Corp in search of a potential trend change.

Keywords: lowest debt-to-capital ratio :enz enzo biochem inc. cambrex corp bio-rad labs-a pacific bioscien bio-techne corp

Ticker(s): CBM BIO PACB TECH